Blog - Page 4055 of 5386

MondayNov 03, 2008 6:01 am

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA)

DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA), an integrated dermatology pharmaceutical company, has its primary focus on developing and marketing its Levulan® Photodynamic Therapy (PDT) technology platform, and complementary dermatology products. Levulan PDT is approved to treat of Grade 1 or 2 actinic keratoses of the face or scalp. ClindaReach is the company’s other dermatology product. Additionally DUSA is researching other indications for Levulan PDT including oral Leukoplakia and the prevention of AKs and SCCs. For further information, visit the Company's web site at www.dusapharma.com.

MondayNov 03, 2008 6:01 am

Alpharma, Inc. (NYSE: ALO)

Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, has an expanding branded franchise within the U.S. pain market with its KADIAN Capsules and the FLECTOR Patch 1.3%. The company is active in over 80 countries and is known throughout the world as a leading provider of pharmaceutical products for poultry and livestock. For further information, visit the Company's web site at www.alpharma.com.

MondayNov 03, 2008 6:00 am

Dune Energy, Inc. (AMEX: DNE)

Dune Energy, Inc. (AMEX: DNE), an independent exploration and development company, has its operations focused along the Louisiana/Texas Gulf Coast. The company currently operates more than 90% of its production and typically maintains a 100% WI. As of January 1, 2008, the company’s proved reserves totaled 175 Bcfe. Dune intends to continue exploiting its existing asset base, while seeking accretive acquisitions and entering into additional joint venture drilling programs. For further information, visit the Company's web site at www.duneenergy.com.

MondayNov 03, 2008 5:59 am

Duluth Metals Limited (TSX: DM CN)

Duluth Metals Limited (TSX: DM CN), a Canadian Corporation, is dedicated to exploring and developing copper, nickel and platinum group metal (PGM) deposits within the emerging Duluth Complex mining camp in northeastern Minnesota, USA. The company’s asset, Nokomis Deposit, is estimated to contain 449 million tonnes of the higher classification resource category of Indicated Resources grading 0.624% copper, 0.199% nickel, 0.600 grams per tonne of total precious metals (TPM = Platinum+Palladium+Gold), and an additional 284 million tonnes of Inferred Resources grading 0.627% copper, 0.194% nickel, 0.718 grams per tonne of TPM. For further information, visit the Company's web site at…

MondayNov 03, 2008 5:58 am

Duckwall-ALCO Stores, Inc. (NASDAQ: DUCK)

Duckwall-ALCO Stores, Inc. (NASDAQ: DUCK) has grown from a company with a single retail store to a 264 store retail chain that operates in 22 states. Although Duckwall has dramatically increased in size, it still maintains a personal mission of providing convenient, friendly small-town service. The company believes its disciplined product presentation, attractive displays, and efficient checkout procedures have made its stores the choice of millions of consumers every month. For further information, visit the Company's web site at http://www.duckwall.com.

MondayNov 03, 2008 5:58 am

Double Eagle Petroleum Co. (NASDAQ: DBLE)

Double Eagle Petroleum Co. (NASDAQ: DBLE) is focused on exploring, developing and transporting oil and gas in the Rocky Mountains. The company's operations are currently focused on the prolific Rocky Mountain Basins, the Green River Basins and Washakie Basins. The company’s aim is to increase stockholder value by providing a positive and rewarding work environment for employees while operating profitably and expanding assets. For further information, visit the Company's web site at www.dble.us. Duckwall-ALCO Stores, Inc. (NASDAQ: DUCK)

MondayNov 03, 2008 5:57 am

DOR BioPharma, Inc. (OTC BB: DORB)

DOR BioPharma, Inc. (OTC BB: DORB), a late-stage biopharmaceutical company, is committed to developing products that treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases; in addition to vaccines for certain bioterrorism agents. orBec®, DOR's lead product, is a potent, locally acting corticosteroid being developed to treat gastrointestinal Graft-versus-Host disease (GI GVHD), a common and potentially life-threatening complication of bone marrow transplantation. For further information, visit the Company's web site at www.dorbiopharma.com.

MondayNov 03, 2008 5:56 am

Diamond Discoveries International Corp. (OTC BB: DMDD)

Diamond Discoveries International Corp. (OTC BB: DMDD), a wholly owned subsidiary of Diamond Discoveries International Corp., is a U.S. exploration company with executive offices in New York, NY and Toronto Ontario. The company has obtained 100% interest in 91 mining claims (covering 3855 hectares) in the Thetford Mines area of Southern Quebec. The rocks of the Thetford Mines Ophiolite Complex represent a historic chrome resource. For further information, visit the Company's web site at www.platinumdiscoveriescorp.com.

MondayNov 03, 2008 5:55 am

Derma Sciences, Inc. (OTC BB: DSCI)

Derma Sciences, Inc. (OTC BB: DSCI), a global manufacturer and marketer of advanced wound-care products, sells its primary product, MEDIHONEY(TM), around the globe through Derma Sciences and Comvita New Zealand, and is known as the leading brand of honey-based dressings for wounds and burns. MEDIHONEY has been proven to effectively treat a variety of wounds and burns, and was recently the focus of a large-scale randomized controlled trial on leg ulcers. For further information, visit the Company's web site at www.dermasciences.com.

MondayNov 03, 2008 5:54 am

Depomed, Inc. (NASDAQ: DEPO)

Depomed, Inc. (NASDAQ: DEPO), a specialty pharmaceutical company, is devoted to enhancing existing pharmaceutical products. To date, the company has brought two products to market and has developed a pipeline with late-stage product opportunities designed to address common medical conditions. Depomed’s core delivery technology, AcuForm, is a patented, polymer-based technology that improves delivery through gastric retention. For further information, visit the Company's web site at www.depomedinc.com.

Site Search

Company Search